ECRON ACUNOVA  
 
 
 
 
From a full-service CRO serving big Pharma Companies locally, we have grown to a specialty CRO serving small, medium and big sponsors globally.
We thank our investigators, employees and sponsors who are a part of this successful journey and invite you to join us into an exciting future.
 
 
We have successfully conducted:
> 1300 Ph I-IV studies with
> 180,000 patients at
> 13,500 sites in the world leading to
> 200 marketing authorization in six continents.

Although we provide clinical research services to six out of top ten global pharma, the major portion of our service we render to small, medium pharma and biotech companies.

We contribute to drug development in :
  • Diagnostic contrast imaging agents including radio-labelled drugs.
  • Cell therapy, bringing to market allogenic drugs and devices.
  • Biosimilars where we have conducted more than ten biosimilar studies.
  • Affordable and accessible generics.
 
FIND OUT MORE
 
  We offer clinical development services to pharmaceutical, biotechnology, generic, regenerative medicine, nutritional, device and medical diagnostics industries.

Our service quality, therapeutic expertise and global reach have allowed us to grow rapidly, serving demanding clients. We provide an attractive package of services coupled with the ability to rapidly conduct clinical trials utilizing a world class delivery platform.

Our long company history, wide geographic presence, extensive patient access, regulatory credibility, quality standards as well as the cultural diversity and capabilities of our team enhance our client benefits.
 
 
Audits/Certification
Events
September 7-9, 2014
Meet us at NLSD and ECCP, Stockholm
September 18-19, 2014
Meet us at CSO, Amsterdam
October 7-9, 2014
ARM Stem Cell Meeting
Estancia La Jolla CA 92037
Meet Dr. Kher
October 7-9, 2014
Meet us at CPhI, Paris, Booth #3G8. Join Biosimilars talk by D.A.Prasanna @ Speaker’s Corner on 7th Oct 1630H
Career Openings
News
Clinical Research in India –Stakeholder Roundtable anchored by Dr. Kher
'What should the New Indian Govt. do in Clinical Research' by D A Prasanna, Chairman ACRO India
Whitepapers
 
  Disclaimer | Privacy Policy